RCPA BPS Exam common mistakes
RCPA BPS Exam · Understand the traps and how to avoid them.
When asked to classify a cell injury as reversible versus irreversible, candidates list the morphological features they memorised (cell swelling, fatty change, karyolysis) but never state the operational threshold that separates the two, so the answer reads as a glossary rather than a decision.
Cell injury is taught as a list of appearances rather than as a sequence of biochemical events (ATP depletion, mitochondrial permeability transition, membrane integrity loss), so candidates cannot say which event commits the cell to death. Under time pressure they default to naming features.
What to do instead
Rehearse a two-column drill: for each injury mechanism (hypoxia, free radical, chemical, ischaemia-reperfusion) write the point of no return in one line (e.g. irreversible mitochondrial permeability transition plus plasma membrane rupture), then attach the morphology to that point. Practise answering 'at what stage and why' before 'what does it look like'.
Candidates describe acute inflammation as a single generic cascade and cannot specify which mediator drives which component (vasodilatation, increased permeability, chemotaxis, pain, fever), or which cell type dominates at each time point of a named lesion.
Mediators are memorised as a flat list (histamine, bradykinin, leukotriene B4, IL-1, TNF) without being mapped onto vascular versus cellular events or onto a timeline. The exam asks for the mapping, not the list.
What to do instead
Build a mediator-to-function matrix and a neutrophil-then-macrophage timeline, then apply both to three concrete scenarios (skin abscess, lobar pneumonia, viral hepatitis). For each scenario state the dominant mediator, the dominant cell, and the resulting histological picture in one sentence.
On wound healing and repair questions, candidates answer with the phases of healing but omit the variables that determine whether healing is by primary intention, secondary intention, or fails (infection, glucocorticoids, diabetes, poor perfusion, foreign body, tension, radiation), and they conflate granulation tissue with scar.
The phases are memorable and easy to reproduce, so candidates stop there. The discriminating marks are in the modifiers, and the granulation-versus-scar distinction is often blurred because both look fibrous at low power.
What to do instead
For every healing question, write the default pathway, then list at least four modifiers with the mechanism by which each impairs healing, and define granulation tissue by its components (proliferating capillaries, fibroblasts, inflammatory cells, oedema) against mature scar (collagen, few vessels, few cells). Practise one short-answer per modifier.
Candidates use 'benign versus malignant' as a checklist of features without weighting them, so they call a tumour malignant because it is large or has mitoses, or benign because it is encapsulated, and they cannot distinguish grade from stage or explain which one predicts outcome.
Feature lists are taught without hierarchy or context. High mitotic rate in a reactive or benign lesion, and absent capsule in many malignant tumours, are common traps; grade and stage are memorised as definitions but not as prognostic tools with different information content.
What to do instead
Rank discriminating features by reliability (metastasis, invasion, cytological anaplasia and pleomorphism, abnormal mitoses, loss of polarity) and practise stating which single feature is decisive in a given vignette. Learn grade as differentiation and stage as anatomical extent, and be able to say which is the stronger prognosticator for a named cancer.
Candidates describe metastasis as a generic 'spread' and cannot order the cascade (detachment, invasion of basement membrane, intravasation, survival in circulation, arrest, extravasation, colonisation) or name the molecular determinants at each step, and they give the anatomical site of a metastasis without the venous drainage or seeding route that explains it.
The cascade is learned as a phrase rather than as a sequence of barriers, and the 'seed and soil' concept is quoted without the mechanistic detail (adhesion molecules, matrix metalloproteinases, immune evasion, dormancy) that the question is testing.
What to do instead
Write the cascade as seven numbered barriers and, for each, one molecule and one therapeutic or biological implication. Then take three examples (colorectal to liver via portal drainage, breast to bone, ovarian transcoelomic) and explain each route in two sentences. Rehearse the difference between invasion and metastasis explicitly.
In haemostasis questions, candidates recite the clotting cascade but cannot integrate it with platelet function, the vessel wall, fibrinolysis, and the laboratory tests, so they misread a prolonged APTT with a normal PT, or they interpret a low fibrinogen or raised D-dimer in isolation.
The cascade is taught as a linear diagram separate from the tests and from the clinical picture. Candidates therefore cannot map a test abnormality onto a factor, an inhibitor, or a consumptive process, and they treat D-dimer as diagnostic rather than sensitive but non-specific.
What to do instead
Build a single integrated sheet: intrinsic and extrinsic pathways with the factors each test probes, the common pathway, platelet adhesion-aggregation-secretion, and the fibrinolytic arm. For each abnormal pattern (isolated prolonged APTT, both prolonged, isolated prolonged PT, low platelets with schistocytes) write a short differential with the next confirmatory test. Always state that D-dimer is a rule-out aid.
When answering transfusion or immunohaematology items, candidates know the ABO and Rh systems but cannot reason through an incompatible transfusion reaction, the basis of the antibody screen and crossmatch, or the mechanism of haemolytic disease of the newborn, and they confuse acute with delayed reactions.
Blood group antigens are memorised as a table without the underlying immunology (naturally occurring IgM versus immune IgG, complement activation, extravascular versus intravascular haemolysis), so candidates cannot derive the clinical picture or the timing from first principles.
What to do instead
For each of acute haemolytic, delayed haemolytic, febrile non-haemolytic, allergic, TRALI and TACO, write the mechanism, the timing, and the key laboratory finding in one line. Then explain why the antibody screen uses indirect antiglobulin testing and why group O negative is used in emergencies. Derive HDFN from IgG crossing the placenta.
On immunology questions, candidates describe hypersensitivity reactions or immunodeficiency by example only, so they can name coeliac disease or myasthenia gravis but cannot assign the mechanism (type II versus type III versus type IV) or predict which component of the immune system is deficient from the pattern of infections.
Learning by disease example without the underlying effector mechanism means the classification collapses when a novel or unfamiliar vignette is presented. The infection-pattern-to-immune-defect mapping is rarely rehearsed.
What to do instead
Anchor each hypersensitivity type to its effector (IgE and mast cells, IgG on fixed antigen, immune complexes, T cells), then test yourself by assigning ten diseases cold. Separately drill the infection pattern to defect map (encapsulated organisms and antibody or complement, intracellular organisms and T cells, recurrent staphylococcal and neutrophil defects, viral and fungal and combined defects).
In microbiology, candidates answer with the organism name but omit the virulence mechanism, the host response, and the specimen-and-stain logic, and they treat antibiotic choice as memorised trivia rather than as a consequence of cell wall, ribosomal, or nucleic acid targets.
Organism lists are easier to revise than pathogenesis and pharmacology, so revision time is skewed toward naming. Candidates then lose marks on 'how does it cause disease' and 'why this drug', and they cannot reason when the organism is not named in the stem.
What to do instead
For each high-yield organism, write three lines: virulence factor, characteristic host response or histology, and drug target class. Learn the antibiotic classes by their molecular target so an unfamiliar organism can still be reasoned about. Practise stems where only the Gram stain, growth requirement, or lesion is given.
On chemical pathology and metabolic items, candidates quote reference intervals and single analyte values without interpreting them in context, ignore units and sample handling (haemolysis, delayed separation, fasting status), and fail to construct a stepwise investigation of a metabolic or acid-base problem.
Analytes are revised as isolated numbers rather than as physiology, and the arithmetic of anion gap, osmolal gap, and compensation is not practised under time pressure. Pre-analytical error is treated as a footnote rather than as a common cause of a spurious result.
What to do instead
Practise a fixed interpretation sequence for every biochemistry stem: confirm units and sample conditions, calculate derived values (anion gap, corrected calcium, osmolality, expected compensation), then generate a ranked differential and state the next test. Rehearse five worked acid-base cases and five electrolyte cases end to end, including the pre-analytical pitfalls for each analyte.
In genetics and molecular pathology, candidates confuse the levels of variant classification (pathogenic, likely pathogenic, variant of uncertain significance), conflate analytical sensitivity with clinical utility of a test, and cannot link a mutation type to its functional consequence (loss of function, dominant negative, gain of function, trinucleotide repeat).
Molecular terms are learned as vocabulary without the framework that connects variant type, functional effect, inheritance pattern, and appropriate test. Candidates therefore overcall a variant of uncertain significance as causative or underuse family studies and predictive testing logic.
What to do instead
Build a consequence table: variant class, predicted protein effect, typical inheritance, and confirmatory test. Learn the ACMG-style classification categories as a hierarchy and practise assigning a variant to a category from a short description. For each of the major mutation mechanisms (missense, nonsense, frameshift, splice site, expansion, imprinting) write one disease example and its mechanism.
On systematic pathology items, candidates list the diseases of an organ without linking them to the shared mechanism, so they cannot explain why a common pathway (ischaemia, hypertension, fibrosis, immune complex deposition) produces different patterns in kidney, lung, liver, and heart, or why a systemic disease produces a particular organ lesion.
Organ systems are revised in silos, and candidates do not carry forward the general pathology principles from domains one to three into organ-based questions. The result is recall of disease names without mechanistic explanation, which the exam rewards poorly.
What to do instead
For each major organ, write the three or four final common pathways (for example glomerular injury patterns, interstitial lung disease patterns, hepatic injury patterns) and attach two diseases to each. Then take one systemic process (hypertension, amyloidosis, diabetes) and trace its effect through four organs. This cross-linking also consolidates the general pathology domains.